Average Co-Inventor Count = 3.75
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Adt Pharmaceuticals, LLC (12 from 12 patents)
2. University of South Alabama (2 from 66 patents)
3. Jiangsu Mingma Biotech Co., Ltd. (2 from 3 patents)
16 patents:
1. 12479813 - Method of therapeutically treating cancer
2. 11834404 - Derivatives of sulindac can protect normal cells against oxidative damage
3. 11680073 - Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses
4. 11407727 - Indenyl compounds, pharmaceutical compositions, and medical uses thereof
5. 11198679 - Method of treating or preventing Ras-mediated diseases
6. 11186596 - Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses
7. 11186534 - Derivatives of sulindac can protect normal cells against oxidative damage
8. 11130744 - Indenyl compounds, pharmaceutical compositions, and medical uses thereof
9. 11104658 - Method of treating or preventing Ras-mediated diseases
10. 10981886 - Indenyl compounds, pharmaceutical compositions, and medical uses thereof
11. 10975054 - Indenyl compounds, pharmaceutical compositions, and medical uses thereof
12. 10526307 - Indenyl compounds, pharmaceutical compositions, and medical uses thereof
13. 10077477 - Serum/plasma MicroRNAs and uses thereof
14. 10011880 - Serum/plasma MicroRNAs and uses thereof
15. 9931315 - Method of selectively inhibiting Ras-mediated tumor growth in humans